Effects of Ophiopogon japonicus oligosaccharides on type 2 diabetes in rats via modulation of gut microbiota and metabolites
Frontiers in Pharmacology · 20.11.2025 · 16
DOI: 10.3389/fphar.2025.1710883 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 20.11.2025. Verfasst von Tingyu Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Chinese Medicine Guangdong Laboratory, Guangdong, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Introduction
Ophiopogon japonicus oligosaccharides (OJO) is a bioactive component extracted and purified from the traditional Chinese medicinal herb Radix Ophiopogonis (Maidong) with significant hypoglycemic effects, although its mechanism of action remains to be further studied.
Methods
This study used a high-fat diet supplemented with streptozotocin to establish a rat model of type 2 diabetes mellitus (T2DM). OJO was administered at low, medium, and high doses for four consecutive weeks. Biochemical indices of glucose and lipid metabolism were measured, and feces, serum, and colonic contents were collected for 16 S rRNA gene sequencing, metabolomics, and gas chromatography–mass spectrometry.
Results
OJO treatment significantly alleviated polyuria and weight loss, ameliorated insulin resistance, and improved glucose and lipid metabolism disorders in T2DM rats. OJO also modulated gut microbiota composition by increasing the Firmicutes -to- Bacteroidota ratio and regulating key bacterial genera, including decreased Lactobacillus and Prevotella and increased unclassified_f_ Lachnospiraceae, Faecalibaculum , norank_f_norank_o_Clostridia_ UCG-014, Christensenellaceae _R-7_group , Romboutsia , and UCG-005. Additionally, OJO significantly reduced acetic acid and propanoic acid levels. Serum untargeted metabolomic analysis revealed that OJO modulated 40 diabetes-associated metabolites, primarily linked to the synthesis and metabolic pathways of aromatic amino acids and bile acids. Correlation analysis identified significant connections between these metabolic alterations and specific gut microbiota.
Conclusion
OJO exhibits therapeutic potential for T2DM, possibly by regulating gut microbiota and associated metabolites.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Chinese Medicine Guangdong Laboratory, Guangdong, China.
- The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
- Guangdong Provincial Hospital of Chinese Medicine, Zhuhai, China.
- Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou, China.
Zitieren
APA
Yang, T., Chen, B., Fang, J., Li, Z., Liu, Y., & Lin, A. (2025). Effects of Ophiopogon japonicus oligosaccharides on type 2 diabetes in rats via modulation of gut microbiota and metabolites. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1710883
Vancouver
Yang T, Chen B, Fang J, Li Z, Liu Y, Lin A. Effects of Ophiopogon japonicus oligosaccharides on type 2 diabetes in rats via modulation of gut microbiota and metabolites. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1710883
BibTeX
@article{Yang2025,
author = {Yang, Tingyu and Chen, Baoting and Fang, Jia and Li, Zilin and Liu, Yiming and Lin, Aihua},
title = {Effects of Ophiopogon japonicus oligosaccharides on type 2 diabetes in rats via modulation of gut microbiota and metabolites},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1710883}
}
EUVIMED